A Phase 3, Multicenter, Randomized, Double-blind Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in Subjects With Red Blood Cell Transfusion-dependent Anemia and Thrombocytopenia Due to IPSS Lower-risk Myelodysplastic Syndromes.
A Phase 3, Multicenter, Randomized, Double-blind Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in Subjects With Red Blood Cell Transfusion-dependent Anemia and Thrombocytopenia Due to IPSS Lower-risk Myelodysplastic Syndromes.
Evaluation of the Efficacy and Safety of Oral Azacitidine plus Best Supportive care versus Placebo and Best Supportive care in subjects with red blood cell (RBC) transfusion-dependent anemia and thrombocytopenia due to International Prognostic Scoring System (IPSS) lower risk myelodysplastic syndromes (MDS).
Inclusion Criteria:
Exclusion Criteria:
Beverly Hills, California 90211, United States
Escondido, California 92025, United States
Kansas City, Missouri 64128, United States
New York, New York 10021, United States
Philadelphia, Pennsylvania 19104, United States
Fort Sam Houston, Texas 78235-8200, United States
Milton, Brisbane, 4064, Australia
Keil, 24105, Germany
Torrette Di Ancona, 60020, Italy
Venezia - Mestre, 30174, Italy
Harrow Middlesex, HA1 3UJ, United Kingdom